Superiority of Rocuronium Reversed with Sugammadex for Obese Patients Anesthesia: A Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2018
Price : $35 *
At a glance
- Drugs Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Cisatracurium besilate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 30 Aug 2018 Status changed from not yet recruiting to recruiting.
- 30 Aug 2018 Planned End Date changed from 1 Apr 2019 to 1 Jul 2020.
- 05 Mar 2018 New trial record